McKesson's Omar Hafez and Pete Perron discuss some of their takeaways working with biosimilars in the community clinic space.
From Clinical Use to Reimbursement Dr. Robert Rifkin, medical director of biosimilars for McKesson, gives an update on biosimilar education and reimbursement.
Confidentiality Notice: This e-mail message is for the sole use of the intended recipients and may contain confidential and privileged information. Any unauthorized review, use, disclosure or distribution is prohibited.